These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 4640658

  • 1. Pulmonary tuberculosis in well-treated alcoholics. Long-term prognosis regarding relapses compared with non-alcoholic patients.
    Kok-Jensen A.
    Scand J Respir Dis; 1972; 53(4):202-6. PubMed ID: 4640658
    [No Abstract] [Full Text] [Related]

  • 2. The prognosis of pulmonary tuberculosis under modern treatment.
    Thomassen OK.
    Scand J Respir Dis Suppl; 1968; 63():29-32. PubMed ID: 5188461
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
    Engbaek HC, Larsen SO, Rasmussen KN, Vergmann B.
    Ugeskr Laeger; 1973 Aug 20; 135(34):1795-9. PubMed ID: 4592618
    [No Abstract] [Full Text] [Related]

  • 4. A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
    Cheung OT, Pugsley HE.
    Can Med Assoc J; 1968 Jun 22; 98(25):1182-3. PubMed ID: 5657185
    [No Abstract] [Full Text] [Related]

  • 5. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E, Abadi O, Pretet S.
    Rev Tuberc Pneumol (Paris); 1969 Nov 22; 33(7):967-74. PubMed ID: 5402999
    [No Abstract] [Full Text] [Related]

  • 6. [Controlled intermittent treatment of pulmonary tuberculosis using streptomycin, isoniazid and PAS once, twice or 3 times a week].
    el-Fassi el-Fahri M, Burzoni FJ, Durante C, Ceicu A.
    Bull Int Union Tuberc; 1973 Dec 22; 48 Suppl():158-65. PubMed ID: 4611550
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct 22; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 8. Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
    Kok-Jensen A, Torning K.
    Scand J Respir Dis Suppl; 1969 Oct 22; 69():17-20. PubMed ID: 4906371
    [No Abstract] [Full Text] [Related]

  • 9. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W, Buraczewska M, Pichulowa K, Pszonicka A, Zych D.
    Gruzlica; 1968 Oct 22; 37(1):17-21. PubMed ID: 5720034
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G, Petitjean R, Schranz J, Scherrer B.
    Rev Tuberc Pneumol (Paris); 1970 Oct 22; 34(3):439-53. PubMed ID: 5515514
    [No Abstract] [Full Text] [Related]

  • 11. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K.
    Scand J Respir Dis Suppl; 1969 Oct 22; 69():21-2. PubMed ID: 5264216
    [No Abstract] [Full Text] [Related]

  • 12. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J, Krychniak W, Krakówka P, Buraczewska M.
    Pol Med J; 1966 Oct 22; 5(2):339-44. PubMed ID: 5915720
    [No Abstract] [Full Text] [Related]

  • 13. [Viral hepatitis and pulmonary tuberculosis].
    Agraval PD.
    Ter Arkh; 1975 Oct 22; 47(8):71-4. PubMed ID: 1237940
    [No Abstract] [Full Text] [Related]

  • 14. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA.
    Probl Tuberk; 1967 Oct 22; 45(5):21-6. PubMed ID: 5617940
    [No Abstract] [Full Text] [Related]

  • 15. [Follow-up studies up to 2 years of pulmonary tuberculosis patients submitted to the primary chemotherapy for 1 year with multiple drugs including ethambutol].
    Kekkaku; 1973 Apr 22; 48(4):135-41. PubMed ID: 4721805
    [No Abstract] [Full Text] [Related]

  • 16. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M.
    Pol Med J; 1967 Apr 22; 6(3):604-9. PubMed ID: 6038083
    [No Abstract] [Full Text] [Related]

  • 17. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA.
    Z Tuberk Erkr Thoraxorg; 1965 Jul 22; 123(4):342-3. PubMed ID: 5897865
    [No Abstract] [Full Text] [Related]

  • 18. [Ambulatory intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rudoĭ NM, Simonian LK.
    Klin Med (Mosk); 1973 Jul 22; 51(7):89-92. PubMed ID: 4786268
    [No Abstract] [Full Text] [Related]

  • 19. Follow-up of patients with pulmonary tuberculosis adequately treated by chemotherapy: is this really necessary?
    Pearce SJ, Horne NW.
    Lancet; 1974 Sep 14; 2(7881):641-3. PubMed ID: 4137673
    [No Abstract] [Full Text] [Related]

  • 20. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J, Janczy S, Buraczewska M, Korlakowski J, Zych D, Krychniak W.
    Pol Med J; 1966 Sep 14; 5(3):526-32. PubMed ID: 5920266
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.